CMT 170 Cell Line

Cat. #153332

CMT 170 Cell Line

Cat. #: 153332

Unit size: 1x10^6 cells / vial

Organism: Mouse

Tissue: Lung

Disease: Cancer

Model: Tumour line


This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.


Inventor: Leonard Franks

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Related Tools

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: CMT 170 Cell Line
  • Cancer: Lung cancer
  • Cancers detailed: Lung carcinoma;Metastatic
  • Research fields: Cancer
  • Organism: Mouse
  • Tissue: Lung
  • Disease: Cancer
  • Growth properties: Tumorigenesis
  • Model: Tumour line
  • Description: The tumourigenic and metastatic CMT 170 murine cell line is sub-line of CMT 64 and an in vivo mouse tumourigenesis system to study the growth characteristics and metastasis of mouse tumour lines. it demonstrates stable growth characteristics and morphology in culture and in lung metastasis induced after subcutaneous inoculation of mice. CMT 170 was selected as a sub-line of CMT 64 for its increased metastatic ability.
  • Production details: Mouse; CMT-170 isolated from primary alveogenic lung carcinoma tumour mass in C57BL/lcrf mouse, achieving stable morphology and growth rate in culture, similar to growth rate and morphology in primary tumour, and in lung metastasis induced after subcutaneous innoculation of mice.
  • Cellosaurus id: CVCL_B492


  • Format: Frozen
  • Growth medium: DMEM with 10% FCS, supplemented with 20mM Hepes.
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

Related Tools

  • Related tools: CMT 64 Cell Line


  • Franks et al. 1984. Br J Cancer. 49(4):423-9. PMID: 6324837.
  • Ultrastructural tumour differentiation and organ specificity in high and low metastatic lines from a mouse lung carcinoma.